MolDX Local Coverage Determination (LCD) and Medical Coverage Database (MCD) Article Updates: Part A and Part B

Published 10/15/2021

The following MolDX LCDs were revised:

  • MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer L37870
  • MolDX: MGMT Promoter Methylation Analysis L35974

The following MCD Articles were revised:

  • Billing and Coding: MolDX: MGMT Promoter Methylation Analysis A56941
  • Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer A54795
  • Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) A56593
  • Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells A58021
  • Billing and Coding: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer A56924

The following MolDX LCDs were retired:

  • MolDX: Prolaris™ Prostate Cancer Genomic Assay L35869 
  • MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease L37043

The following MCD Articles were retired:

  • Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease A56911
  • Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay A56918